A-Topics Lectures

MUHC COE AD

A-Topics Lecture Series

Introduction

A-Topics is a bilingual, ‘short-form’ lecture series centered on current understanding of disease, best clinical practices, recent scientific advances, and the latest therapeutic developments in adult Atopic Dermatitis.

Topic
1. Epidemic of Atopy: population and environment
Objectives
  • Explore the presentation of AD in pediatric patients.
  • Understand the transition of AD from childhood into adulthood.
  • Recognize the heterogeneity of the disease in adult patients.
Scientific panel lecturer

Dr. A. Drucker, University of Toronto

Community panel reviewer

KEY POINTS: Derm TRAINEES versus GPs

Dr. Y. Asai, Queens University 

 

 

Topic
2. Translational aspects in pathobiology of AD: Targeting molecular Pathways
Objectives
  • Review the pathophysiology and mechanisms of disease in AD
  • Explore new developments in understanding the pathogenesis of AD
  • Gain clinical insights on selectively targeting mediators of type 2 inflammation in clinical practices
Scientific panel lecturer

Dr. T. Bieber, University of Bonn

Community panel reviewer

Dr. C. Besner Morin, Université de Montréal

Topic
3. Shifting Guidelines for Treatment
Objectives
  • Review current clinical guidelines based on AD severity score
  • Introduce guidelines in development
  • Assess safety and efficacy of treatments of AD
  • Explore AD guidelines in particular populations (children, adults with renal disease…)
Scientific panel lecturer

Dr. M. Kirchhof, University of Ottawa

Community panel reviewer

Dr. M. Bourcier, Université de Sherbrooke

Topic
4. Novel Topical Therapies for the Treatment of Atopic Dermatitis
Objectives
  • Review skin anatomy and the role of the epidermal barrier
  • Understand how to optimize topical therapies in AD
  • Explore new advancements in topical therapies in children and adults with AD
Scientific panel lecturer

Dr. C.-H. Hong, University of British Columbia

Community panel reviewer
Topic
5. Novel Systemic Therapies for the Treatment of Atopic Dermatitis
Objectives
  • Determine who is the best candidate for systemic therapy
  • Explore the use systemic therapies in AD
  • Gain insights on novel systemic therapies
Scientific panel lecturer

Dr. M. Gooderham, Queens University

Community panel reviewer
Topic
6. Addressing Co-Morbidities in Atopic Dermatitis Patients: Asthma, Sinusitis, and Other Complications
Objectives
  • Review the multimorbidity of AD
  • Explore the common role of type 2 inflammation in the shared pathophysiology of atopic dermatitis and other type 2 inflammatory diseases
  • Gain clinical insights on the evaluation and management of atopic comorbidities in atopic dermatitis
Scientific panel lecturer

Part 1
Dr. R. Olivenstein, McGill University

Part 2
Dr. M. Tewfik, McGill University

Community panel reviewer

Part 1
Dr. R. Asiniwasis, University of Saskatchewan

Part 2
Dr. D. Adam, University of Toronto

Topic
7. Knowledge Translation: Using Tools to Facilitate Communication with Patients
Objectives
  • Illustrate the opportunity for patients to improve their management of AD with knowledge translation tools.
  • Demonstrate how dermatologists can take advantage of the wider range of information on their patients.
  • Exhibit the opportunity to improve access to healthcare through communicational tools.
Scientific panel lecturer

Dr. C. Jack, McGill University

Community panel reviewer

Dr. M. Joseph, University of Toronto

Scroll to Top